SJS Investment Consulting’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-17
Closed -$1.08K 1601
2024
Q3
$1.08K Buy
17
+2
+13% +$144 ﹤0.01% 1043
2024
Q2
$1.01K Sell
15
-12
-44% -$838 ﹤0.01% 1020
2024
Q1
$2.14K Buy
27
+1
+4% +$82 ﹤0.01% 717
2023
Q4
$2.02K Buy
26
+6
+30% +$444 ﹤0.01% 661
2023
Q3
$1.41K Sell
20
-1
-5% -$75 ﹤0.01% 781
2023
Q2
$1.67K Buy
21
+12
+133% +$867 ﹤0.01% 672
2023
Q1
$651 Sell
9
-19
-68% -$1.48K ﹤0.01% 1053
2022
Q4
$2.31K Buy
28
+6
+27% +$495 ﹤0.01% 575
2022
Q3
$1K Buy
+22
New +$1.76K ﹤0.01% 579
2022
Q1
$0 Buy
+3
New +$174 ﹤0.01% 663

Other funds holding ACHC

SJS Investment Consulting's ACHC Position: Q4 2024 in Review

SJS Investment Consulting sold out of Acadia Healthcare (ACHC) in Q4 2024, closing a stake of 17 shares — an estimated $1.08K sold.

SJS Investment Consulting first reported a position in ACHC in Q1 2022 and held it in 10 quarters. The position peaked at $2.31K in Q4 2022. 306 funds tracked by Wall St. Rank hold ACHC as of Q4 2024.

  • SJS Investment Consulting reported no remaining Acadia Healthcare position as of Q4 2024 after selling out during the quarter.
  • SJS Investment Consulting sold 17 Acadia Healthcare shares in Q4 2024, an estimated $1.08K.
  • SJS Investment Consulting first reported a position in Acadia Healthcare in Q1 2022 and held it in 10 quarters.
  • SJS Investment Consulting's Acadia Healthcare position peaked at $2.31K in Q4 2022.
  • 306 funds tracked by Wall St. Rank held Acadia Healthcare as of Q4 2024.

Based on SJS Investment Consulting's 13F filing for Q4 2024, filed 21 Jan 2025.